Prostate biopsy · North Carolina
Prostate biopsy in North Carolina: the highest-volume physicians
133 physicians in North Carolina billed Medicare for 3,198 prostate biopsy procedures in 2024. The top 25, with the year before beside it.
Top 25
| Rank | Physician | 2024 | 2023 | Change |
|---|---|---|---|---|
| 1 | Thomas J. Polascik, MDUrology · Durham | 87 | 90 | −3% |
| 2 | Jonathan H. Taylor, MDUrology · Greenville | 73 | 91 | −20% |
| 3 | Greg L. Griewe, MDUrology · Pinehurst | 65 | 68 | −4% |
| 3 | Mark W. Jalkut, MDUrology · Raleigh | 65 | 60 | +8% |
| 5 | Roc A. Mccarthy, DOUrology · Whiteville | 61 | 40 | +53% |
| 5 | Michael B. Rothberg, MDUrology · Durham | 61 | 11 | |
| 7 | Michael B. Burris, MDUrology · Asheville | 57 | 52 | +10% |
| 8 | Jeremy S. Hubbard, MDUrology · Charlotte | 54 | 38 | +42% |
| 9 | David B. Konstandt, MDUrology · Mooresville | 53 | 47 | +13% |
| 10 | Judd Moul, MDUrology · Durham | 51 | 59 | −14% |
| 11 | Michael MoranUrology · Whiteville | 47 | 21 | +124% |
| 12 | Roland M. Friedman, MDUrology · Winston Salem | 46 | 52 | −12% |
| 13 | Stewart M. Polsky, MDUrology · Mooresville | 45 | 20 | +125% |
| 14 | William B. Townsend, MDUrology · Charlotte | 41 | 55 | −25% |
| 15 | Kush S. Patel, MDUrology · Statesville | 39 | 44 | −11% |
| 15 | Manish Damani, MDUrology · Charlotte | 39 | 25 | +56% |
| 15 | Michael B. Smigelski, MDUrology · Charlotte | 39 | 13 | |
| 15 | Jeffrey H. Martin, MD PAUrology · Murphy | 39 | 32 | +22% |
| 19 | Eric M. Wallen, MDUrology · Chapel Hill | 37 | 39 | −5% |
| 19 | Hal B. Hooper, MDUrology · Asheville | 37 | 33 | +12% |
| 21 | Soroush Rais-Bahrami, MDUrology · Winston Salem | 36 | 32 | +13% |
| 21 | Dominic C. Grimberg, MDUrology · Asheville | 36 | — | |
| 23 | Marc Bjurlin, DOUrology · Kinston | 33 | 41 | −20% |
| 23 | James C. Brien, MDUrology · Asheville | 33 | 37 | −11% |
| 23 | Clay D. Martin, MDUrology · Wilmington | 33 | — |
A rank counts procedures billed under the physician's own NPI (CPT 55700), in 2024, Medicare fee-for-service only. A surgeon who mostly treats younger or Medicare Advantage patients will rank lower than their total volume. Method and limits.